We are live on
!
Find out more
NVLN
Novelion Therapeutics Inc. Common Shares
NVLN
NVLN
Delisted
NVLN was delisted on the 8th of October, 2019.
66 hedge funds and large institutions have $110M invested in Novelion Therapeutics Inc. Common Shares in 2016 Q4 according to their latest regulatory filings, with 66 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
368% more call options, than puts
Call options by funds: $2.85M | Put options by funds: $610K
Holders
66
Holders Change
+66
Holders Change %
–
% of All Funds
1.65%
Holding in Top 10
4
Holding in Top 10 Change
+4
Holding in Top 10 Change %
% of All Funds
0.1%
New
66
Increased
–
Reduced
–
Closed
–
Calls
$2.85M
Puts
$610K
Net Calls
+$2.25M
Net Calls Change
+$2.25M
Top Buyers
| 1 |
BC
Broadfin Capital
New York
|
+$17.3M |
| 2 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$13.5M |
| 3 |
AC
Armistice Capital
New York
|
+$12.6M |
| 4 |
SCM
Scopia Capital Management
New York
|
+$10.4M |
| 5 |
SCM
Sarissa Capital Management
Greenwich,
Connecticut
|
+$9.08M |
Top Sellers
No sellers this quarter
